Divi's Laboratories share price
You have to be logged in to add this to Watchlist.- ₹6,656.45(-3.34%)November 7, 2025 15:50:01 PM IST
- NSE
- BSE
- Vol : 878.47K (NSE + BSE)Last 20 day avg : 538.08 K
Divi's Laboratories is trading -3.34% lower at Rs 6,656.45 as compared to its last closing price. Divi's Laboratories has been trading in the price range of 6,884.25 & 6,602.65. Divi's Laboratories has given 12.87% in this year & 5.70% in the last 5 days. Divi's Laboratories has TTM P/E ratio 78.36 as compared to the sector P/E of 37.38.There are 26 analysts who have initiated coverage on Divi's Laboratories. There are 5 analysts who have given it a strong buy rating & 7 analysts have given it a buy rating. 6 analysts have given the stock a sell rating.The company posted a net profit of 545.00 Crores in its last quarter.Listed peers of Divi's Laboratories include Sun Pharmaceutical Industries (0.42%), Divis Laboratories (-3.34%), Cipla (0.29%).The Mutual Fund holding in Divi's Laboratories was at 13.99% in 30 Sep 2025. The MF holding has increased from the last quarter. The FII holding in Divi's Laboratories was at 19.39% in 30 Sep 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Nov 08, 2025, 06:44 AM UTC
- BetaLow volatility0.72Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.00The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.44Annual dividends as a percentage of the stock price.
- P/BHigher than historical values12.21The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values79.21Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates undervaluation-8.30The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is profitable- The company's revenue grew in June quarter by 13.79% from Rs 2410.00 crore to Rs 2118.00 crore, year-on-year
- The company has grown its June quarter profit by 26.74% from Rs 430.00 crore to Rs 545.00 crore, year-on-year
- The debt to equity of the company is lower than the industry median
- R1
- 6,939.18
- R2
- 7,072.72
- R3
- 7,240.98
- S1
- 6,637.38
- S2
- 6,469.12
- S3
- 6,335.58
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | Bullish | 1,692.75 | 0.42 | 4,06,137.52 | 33.93 | 5.58 | 0.95 | 0.50 |
| Divis Laboratories | Bullish | 6,656.45 | -3.34 | 1,77,130.97 | 82.64 | 12.19 | 0.44 | 0.01 |
| Cipla | Moderately Bearish | 1,504.45 | 0.29 | 1,21,524.31 | 23.14 | 3.91 | 0.86 | 0.81 |
| Torrent Pharmaceuticals | Bullish | 3,575.00 | 0.58 | 1,20,517.52 | 58.52 | 14.87 | 0.96 | 17.63 |
| Dr Reddys Laboratories | Bearish | 1,205.30 | 0.02 | 1,00,591.29 | 19.00 | 3.2 | 0.62 | 2.34 |
- Promoter(s) holds a high stake in the company at 51.89%
- FIIs are invested in this company
FIIs holding has decreased by 0.35 percentage points from previous quarter- Mutual Funds holding has increased by 0.68 percentage points from previous quarter
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-07 | Quarterly Results |
| 2025-08-06 | Quarterly Results |
| 2025-05-17 | Audited Results & Dividend |
| 2025-02-03 | Quarterly Results |
| 2024-11-09 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE361B01024
- BSE Code532488
- NSE CodeDIVISLAB
Divi's Laboratories is trading at 6656.45 as on Fri Nov 07 2025 10:20:01. This is -3.34% lower as compared to its previous closing price of 6886.30.
The market capitalization of Divi's Laboratories is 177130.97 Cr as on Fri Nov 07 2025 10:20:01.
The average broker rating on Divi's Laboratories is Hold. The breakup of analyst rating is given below -
- 5 analysts have given a strong buy rating
- 7 analysts have given a buy rating
- 5 analysts have given a hold rating
- 6 analysts have given a sell rating
- 3 analysts have given a strong sell rating
The 52 wk high for Divi's Laboratories is 7077.70 whereas the 52 wk low is 4941.70
Divi's Laboratories can be analyzed on the following key metrics -
- TTM P/E: 78.36
- Sector P/E: 37.38
- Dividend Yield: 0.44%
- D/E ratio: -
Divi's Laboratories reported a net profit of 2191.00 Cr in 2025.
The Mutual Fund Shareholding was 13.99% at the end of 30 Sep 2025.